FY2026 EPS Estimates for Centene Decreased by Zacks Research

Centene Co. (NYSE:CNC) – Zacks Research decreased their FY2026 EPS estimates for shares of Centene in a research note issued to investors on Tuesday, June 10th. Zacks Research analyst K. Dey now forecasts that the company will earn $7.58 per share for the year, down from their previous estimate of $7.60. The consensus estimate for Centene’s current full-year earnings is $6.86 per share. Zacks Research also issued estimates for Centene’s Q1 2027 earnings at $3.26 EPS.

Several other research analysts have also weighed in on CNC. Wells Fargo & Company dropped their price objective on shares of Centene from $76.00 to $72.00 and set an “overweight” rating on the stock in a research note on Friday, February 14th. Jefferies Financial Group dropped their price target on shares of Centene from $64.00 to $61.00 and set a “hold” rating on the stock in a research note on Tuesday, April 29th. Morgan Stanley initiated coverage on shares of Centene in a research note on Monday, June 9th. They set an “overweight” rating and a $70.00 price target on the stock. Barclays restated an “equal weight” rating and set a $65.00 price target (down previously from $84.00) on shares of Centene in a research note on Monday, June 2nd. Finally, Robert W. Baird dropped their price target on shares of Centene from $71.00 to $69.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 15th. Seven research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Centene has a consensus rating of “Moderate Buy” and a consensus price target of $77.71.

Centene Stock Down 0.3%

Centene stock opened at $55.20 on Friday. The firm has a market cap of $27.47 billion, a PE ratio of 8.85, a P/E/G ratio of 0.80 and a beta of 0.45. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11. The firm’s 50 day moving average price is $59.29 and its two-hundred day moving average price is $59.92. Centene has a twelve month low of $54.01 and a twelve month high of $80.59.

Centene (NYSE:CNC) last released its quarterly earnings data on Friday, April 25th. The company reported $2.90 earnings per share for the quarter, beating the consensus estimate of $2.52 by $0.38. The firm had revenue of $46.62 billion for the quarter, compared to analyst estimates of $43.16 billion. Centene had a net margin of 2.03% and a return on equity of 13.85%. The company’s revenue for the quarter was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.26 EPS.

Institutional Trading of Centene

A number of hedge funds have recently bought and sold shares of CNC. Capital Advisors Ltd. LLC boosted its holdings in Centene by 75.3% in the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock valued at $25,000 after purchasing an additional 177 shares during the period. Pinney & Scofield Inc. bought a new stake in Centene in the 4th quarter valued at $25,000. Hurley Capital LLC bought a new position in shares of Centene during the 4th quarter worth about $26,000. Ameriflex Group Inc. bought a new position in shares of Centene during the 4th quarter worth about $26,000. Finally, Quarry LP bought a new position in shares of Centene during the 1st quarter worth about $26,000. 93.63% of the stock is owned by institutional investors.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.